A detailed history of Samalin Investment Counsel, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Samalin Investment Counsel, LLC holds 20,282 shares of PFE stock, worth $601,564. This represents 0.27% of its overall portfolio holdings.

Number of Shares
20,282
Previous 19,257 5.32%
Holding current value
$601,564
Previous $534,000 6.18%
% of portfolio
0.27%
Previous 0.26%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$25.26 - $29.6 $25,891 - $30,340
1,025 Added 5.32%
20,282 $567,000
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $15,119 - $17,362
584 Added 3.13%
19,257 $534,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $192,342 - $249,832
7,361 Added 65.07%
18,673 $537,000
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $27,661 - $32,333
862 Added 8.25%
11,312 $375,000
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $1,336 - $1,546
37 Added 0.36%
10,450 $383,000
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $28,085 - $36,562
-713 Reduced 6.41%
10,413 $424,000
Q4 2022

Feb 10, 2023

SELL
$41.75 - $54.5 $22,795 - $29,757
-546 Reduced 4.68%
11,126 $570,000
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $34,614 - $42,255
791 Added 7.27%
11,672 $511,000
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $1,535 - $1,820
33 Added 0.3%
10,881 $571,000
Q1 2022

Oct 13, 2022

SELL
$45.75 - $56.69 $21,822 - $27,041
-477 Reduced 4.21%
10,848 $562,000
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $21,822 - $27,041
-477 Reduced 4.21%
10,848 $562 Million
Q4 2021

Oct 13, 2022

BUY
$41.32 - $61.25 $14,007 - $20,763
339 Added 3.09%
11,325 $669,000
Q4 2021

Feb 15, 2022

BUY
$41.32 - $61.25 $14,007 - $20,763
339 Added 3.09%
11,325 $669 Million
Q3 2021

Oct 13, 2022

BUY
$39.25 - $50.42 $15,111 - $19,411
385 Added 3.63%
10,986 $472,000
Q3 2021

Nov 15, 2021

BUY
$39.25 - $50.42 $15,111 - $19,411
385 Added 3.63%
10,986 $472 Million
Q2 2021

Oct 13, 2022

BUY
$35.91 - $40.68 $16,841 - $19,078
469 Added 4.63%
10,601 $415,000
Q2 2021

Aug 12, 2021

BUY
$35.91 - $40.68 $1,544 - $1,749
43 Added 0.41%
10,601 $415,000
Q1 2021

May 11, 2021

BUY
$33.49 - $37.77 $14,266 - $16,090
426 Added 4.2%
10,558 $382,000
Q4 2020

Oct 13, 2022

BUY
$33.47 - $42.56 $16,668 - $21,194
498 Added 5.17%
10,132 $373,000
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $16,668 - $21,194
498 Added 5.17%
10,132 $373 Million
Q3 2020

Oct 13, 2022

SELL
$31.75 - $37.25 $39,592 - $46,450
-1,247 Reduced 11.46%
9,634 $354,000
Q3 2020

Nov 10, 2020

BUY
$31.75 - $37.25 $1,206 - $1,415
38 Added 0.4%
9,634 $335,000
Q2 2020

Aug 05, 2020

BUY
$30.12 - $36.54 $67,438 - $81,813
2,239 Added 30.43%
9,596 $313,000
Q1 2020

May 04, 2020

SELL
$27.03 - $38.62 $243 - $347
-9 Reduced 0.12%
7,357 $240,000
Q4 2019

Feb 05, 2020

BUY
$32.92 - $37.36 $242,488 - $275,193
7,366 New
7,366 $288,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Samalin Investment Counsel, LLC Portfolio

Follow Samalin Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Samalin Investment Counsel, LLC with notifications on news.